ArticleBMC geriatrics2021
Older people's attitudes towards deprescribing cardiometabolic medication.
Article in BMC geriatrics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
27 citing papers in PubMed, 1 synthesis or guideline pooled it, 60 citations in OpenAlex.
- Differences in Older Patients' Attitudes Toward Deprescribing at Contextual and Individual Level.Frontiers in public health · 2022Pooled it
- Trial
- Patient Attitudes and Factors Associated with Willingness to Deprescribe Prescribed Medications in Western Saudi Arabia: A Cross-Sectional Study.Healthcare (Basel, Switzerland) · 2026Article
- Deprescribing Decisions in Swiss Primary Care: Low Concordance Between General Practitioners and Older Adults.Journal of general internal medicine · 2026Article
- Deprescribing & its associated factors among middle & old-aged ambulatory patients with chronic disease (s): A hospital-based cross-sectional study.The Indian journal of medical research · 2025Article
- Engaging Patients in Discussions About Medication Deprescribing.Journal of general internal medicine · 2025Article
- Description of barriers to the deprescription of inappropriate drugs in French hospitalized geriatric services.Scientific reports · 2025Article
- Older Adults' Attitudes Toward Deprescribing in 14 Countries.JAMA network open · 2025Article
- Investigating Older Adults' Perceptions of AI Tools for Medication Decisions: Vignette-Based Experimental Survey.Journal of medical Internet research · 2024Article
- Article
- Attitudes and beliefs towards medication burden and deprescribing in Parkinson disease.BMC neurology · 2024Article
- Deprescribing in older adults in a French community: a questionnaire study on patients' beliefs and attitudes.BMC geriatrics · 2024Article
- Article
- Influence of chronic medical conditions on older patients' willingness to deprescribe medications: a cross-sectional study.BMC geriatrics · 2024Article
- Proceedings of the International Ambulatory Drug Safety Symposium: Munich, Germany, June 2023.Drug safety · 2024Article
- DEprescribing: Perceptions of PAtients living with advanced cancer. A multicentre, prospective mixed observational study protocol.PloS one · 2024Article
- Deprescribing attitudes and predictors among older adults attending geriatric clinics in Kuwait.PloS one · 2024Article
- Letter to the Editor: a Qualitative Study of Perspectives of Older Adults on Deintensifying Diabetes Medications.Journal of general internal medicine · 2023Article
- Attitude towards deprescribing and its association with frailty and complexity of medication regimen: A survey of older inpatients in a district health board in New Zealand.BMC geriatrics · 2023Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 4 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundOvertreatment with cardiometabolic medication in older patients can lead to major adverse events. Timely deprescribing of these medications is therefore essential. Self-reported willingness to stop medication is usually high among older people, still overtreatment with cardiometabolic medication is common and deprescribing is rarely initiated. An important barrier for deprescribing reported by general practitioners is the patients' unwillingness to stop the medication. More insights are needed into the influence of patients' characteristics on their attitudes towards deprescribing and differences in these attitudes between cardiometabolic medication groups.
methodsA survey in older people using cardiometabolic medication using the revised Patients' Attitudes Towards Deprescribing (rPATD) questionnaire was performed. Participants completed the general rPATD and an adapted version for four medication groups. Linear and ordinal logistic regression were used to assess the influence of age, sex, therapeutic area and number of medications used on the patients' general attitudes towards deprescribing. Univariate analysis was used to compare differences in deprescribing attitudes towards sulfonylureas, insulins, antihypertensive medication and statins.
resultsOverall, 314 out of 1143 invited participants completed the survey (median age 76 years, 54% female). Most participants (80%) were satisfied with their medication and willing to stop medications if their doctor said it was possible (88%). Age, sex and therapeutic area had no influence on the general attitudes towards deprescribing. Taking more than ten medicines was significantly associated with a higher perceived medication burden. Antihypertensive medication and insulin were considered more appropriate than statins, and insulin was considered more appropriate than sulfonylureas not favouring deprescribing.
conclusionsThe majority of older people using cardiometabolic medication are willing to stop one of their medicines if their doctor said it was possible. Health care providers should take into account that patients perceive some of their medication as more appropriate than other medication when discussing deprescribing.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.